Cargando…
The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target
Here we show that human papillomavirus (HPV) E6 and E7 oncoproteins induce hWAPL expression. In addition, small interfering RNA (siRNA) of hWAPL suppressed the growth of tumours derived from SiHa cells in nude mice. Thus, hWAPL may be one of the effective targets of uterine cervical cancer therapy.
Autores principales: | Kuroda, M, Kiyono, T, Oikawa, K, Yoshida, K, Mukai, K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361835/ https://www.ncbi.nlm.nih.gov/pubmed/15655544 http://dx.doi.org/10.1038/sj.bjc.6602329 |
Ejemplares similares
-
TAT-mediated si-hWAPL inhibits the invasion and metastasis of cervical cancer stem cells
por: Gong, Pijun, et al.
Publicado: (2017) -
WAPL induces cervical intraepithelial neoplasia modulated with estrogen signaling without HPV E6/E7
por: Kumagai, Katsuyoshi, et al.
Publicado: (2021) -
A novel oncogenic pathway by TLS–CHOP involving repression of MDA-7/IL-24 expression
por: Oikawa, K, et al.
Publicado: (2012) -
REBACIN(®) inhibits E6/E7 oncogenes in clearance of human papillomavirus infection
por: Zhou, Shu-Guang, et al.
Publicado: (2022) -
Oncogenic comparison of human papillomavirus type 58 E7 variants
por: Law, Priscilla TY, et al.
Publicado: (2018)